Correlation between thyroid dysfunction and efficacy of immune checkpoint inhibitors in patients with advanced solid tumors
Abstract Background Immune checkpoint inhibitors (ICIs) are currently the first line of tumor immunotherapy for the treatment of a wide range of tumors. However, the main side effect of immune checkpoint inhibitors is that they cause immune-related adverse events (irAEs) in patients. The relationshi...
Saved in:
Main Author: | Cheng Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-11-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-024-01546-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis
by: Meriç Dökmetaş, et al.
Published: (2025-01-01) -
Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity
by: Dianying Zhang, et al.
Published: (2024-12-01) -
Immune-related thyroid dysfunction as a positive prognostic factor for patients with lung cancer in China: a real-world retrospective study
by: Ge Guo, et al.
Published: (2024-12-01) -
The impact of immune-related adverse events on the outcome of advanced gastric cancer patients with immune checkpoint inhibitor treatment
by: Tianhang Zhang, et al.
Published: (2024-12-01) -
Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors
by: Ichiro Yamauchi, et al.
Published: (2025-01-01)